ClC-1 plays an important part in the maintenance of membrane potential in the mammalian skeletal muscle. To investigate the phosphorylation sites responsible for the effect of PKC (protein kinase C) activator, we constructed 21 different ClC-1 mutants with mutations at predicted phosphorylation sites for PKC. The functional experiments were performed on both wildtype and mutant proteins (17 point mutants and 4 double mutants) expressed in Xenopus oocytes with two-electrode voltage-clamp recording. PMA (12-myristate 13-acetate), a PKC activator, caused a right shift of half-maximum activation potential (V 1/2 ) significantly in the wild-type (from -42.9±4.4 to -13.7±1.7 mV; n = 8, P < 0.05) and most of the single mutants except the S892P (from -39.5±4.5 to -35.7±5.7 mV; n = 6) and S892D (from -10.2±4.9 to -9.6±3.5 mV; n = 4). S892D, a mutant mimicking PKCmediated phosphorylation at position 892, can also mimic the effect of wild-type treated with PMA in V 1/2 value (-10.2±4.9 mV vs -13.7±1.7 mV, n = 4 -8).
Introduction
ClC-1, a chloride channel in mammalian skeletal muscle membrane, plays an important part in the regulation of the membrane excitability [1] . The chloride conductance contributes for ~80% of the total resting conductance in mammalian muscle fibres, and thereby stabilizes resting membrane potential in skeletal muscle. Reductions of chloride conductance of skeletal muscle O 688 by chloride channel inhibitors [2] [3] destabilize the resting potential and lead to a repetitive firing abnormality (also known as myotonia) [4] . Mutations in the ClC-1 gene are responsible for human myotonia congenita that can be either autosomal recessive or autosomal dominant [5] . It has been reported that chloride conductance in skeletal muscle is decreased by phorbol esters, presumably through activation of protein kinase C (PKC) [6] . PKC inhibitor chelerythrine was able to increase the chloride conductance in soleus muscle, suggesting that partial PKC-dependent activation of ClC-1 channels in basal conditions may contribute to the lower chloride conductance in slow-twitch muscles [7] . Furthermore, the staurosporine (a PKC blocker) treatment alone in dissociated fibers culture for 1-2 days indicating chloride conductance is downregulated by a mechanism involving protein phosphorylation [8] . It was also shown that a recombinant human ClC-1 expressed in HEK293 cells is regulated by PKC activators [9] [10] . All of these studies demonstrated that the inhibitory effect of phorbol esters on chloride channel in skeletal muscle is mediated, at least in part via the PKC-dependent pathway. However, the exact position of its phosphorylation sites of ClC-1 is still unknown. The discovery of the gene structure and function of mammalian ClC-1 has been described previously [11, 12] . In human, ClC-1 protein is composed of 988-amino acid, including a 398-amino acid carboxylterminal tail that resides in the cytoplasm and contains two CBS (cystathionine-β-synthase) domains [13] . Functional analysis of human ClC-1 channel showed the PKC appears to affect gating processes and it is suggested that the phosphorylation site may be located at the cytoplasmic region [9] . PKC preferentially phosphorylates serine or threonine residues that are close to a C-terminal basic residue [14] [15] . Bioinformatic tools can help to predict possible phosphorylation sites in the C-terminal region of ClC-1. However, their results must be confirmed through functional experiments. Through the computational prediction, there are about twenty potential phosphorylation sites located at this C-terminal domain; each potential site is recognized by PKC. Therefore we designed and constructed over twenty mutant plasmids by using the methods of site-direct mutagenesis. Wildtype and mutant ClC-1 channels were heterologously expressed in Xenopus laevis oocytes and characterized by measuring whole cell currents with two-microelectrode voltage clamp techniques. Our results explored the residues Thr891-Ser892-Thr893 of ClC-1 are candidates for the effects of PKC activator.
Materials and Methods

PKC phosphorylation sites prediction and site-directed mutagenesis
We use phosphorylation site prediction Netphos server [16] [17] for the prediction of potential PKC phosphorylation sites within the C-terminus of ClC-1. Based on the prediction, we constructed 21 mutant plasmids of human ClC-1, and then expressed each of the ClC-1 mutants in Xenopus oocytes for measurement of the chloride current. For each predicted site was replaced with an appropriate amino acid residue by site-directed mutagenesis method as previous described [18] [19] . The mutations of nucleic acids of ClC-1 mutants and the mutagenic primers used in this study are shown in Table  1 .In brief, the corresponding mutations were introduced into human wild-type CLC-1 cDNA in the pTLN Xenopus oocytes expression vector by recombinant PCR using Pfu turbo DNA polymerase (QuickChange Site-Directed Mutagenesis kit; Stratagene). DNA from these putative mutant colonies was sequenced to confirm the site-directed mutation and to exclude the error sequence.
In vitro transcription
The in vitro transcription of ClC-1 cRNA was performed using a mMESSAGE mMACHINE SP6 Kit (Ambion) according to the manufacturer's protocol. Plasmids were linearized with HpaI, and capped cRNA was transcribed using SP6 RNA polymerase. The cRNA was purified and resuspended in nuclease-free water at a concentration of 1 mg/ml and stored frozen at -80°C in aliquots. The concentration of each RNA was determined by UV spectrophotometry.
Oocytes preparation and microinjection
Female Xenopus laevis frogs were anaesthetized by immersion in 0.15% Tricaine (Sigma-Aldrich, USA) which dissolved in 0.1% sodium bicarbonate solution. The ovarian lobe was then surgically removed from the abdominal cavity through a small incision and placed in modified Barth's solution (MBS) containing the following (in mM): 90 NaCl, 1 KCl, 2.4 NaHCO 3 , 0.82 MgSO 4 , 0.41 CaCl 2 , 0.33 Ca(NO 3 ) 2 , and 10 Hepes-Tris, pH = 7.6. Small pieces of ovarian lobe were dissected out and gently shaken at room temperature for 1 hour in MBS solution supplemented with collagenase type 1 (1-2 mg/ml) followed by five to six washes in MBS. The defolliculated oocytes (Stage V or VI) were then incubated and kept overnight at 17 °C before injection with mRNA. Only healthy-looking oocytes of V-VI stages were selected for microinjection. Wild-type and the mutants cRNA were microinjected into defolliculated Xenopus oocytes (5-10 ng/cell) using a Nanoject microinjector (Drummond, USA). Injected oocytes were kept in sterile MBS at 17-18 °C for 2-3 days before electrophysiological measurements were performed. All experiments conformed to guidelines of the ethical use of animals of the Animal Care Committee of Chung Shan Medical University.
Electrophysiology
Wild type and mutant ClC-1 channels were heterologously expressed in Xenopus oocytes and the currents were recorded by using a two-electrode voltage-clamp amplifier (AxoClamp-2B, Axon Instruments). All electrodes were pulled from borosilicate glass capillaries GC150T4 (Warner Instruments) on a vertical electrode puller (PP-830, Narishige) and filled with 3M KCl solution (0.5 to 2 MΩ). One of the electrodes was used as a voltage recording (connected to an HS-2A x 1 LU headstage) and the other electrode was used for current recording (connected to an HS-2A x10 MGU headstage). The oocytes were placed in a 2 ml recording chamber during experiments and the membrane chloride current was measured in ND 96 solution consisting of (mM): 96 NaCl, 1 KCl, 1 MgCl 2 , 1 CaCl 2 , 5 Hepes; pH was 7.4. All recordings of membrane currents were carried out at room temperature (22-26 °C) . Membrane currents were digitized at 5 kHz through a Digidata 1322A A/D converter, acquired, and analyzed using pClamp 9.0 software. The apparent open probability was determined by a Table 1 . The sequences of the primers used for site-directed mutagenesis in this study. F: forward primer; R: reverse primer. step protocol, whereby the oocytes were clamped at -100 mV and test potentials ranging from -140 to +100 mV in 20 mV increments followed by a constant tail pulse to -80 mV.
Calculations and data analysis
Peak tail currents at this voltage were fitted using a Boltzmann distribution as follows,
is the maximal tail current, V m is the membrane potential, V 1/2 is the halfmaximum activation voltage, and k is the slope factor. Data are presented as means ± SE. Statistical significance was determined using ANOVA and Student's t-test. P values of < 0.05 were taken to indicate statistical significance.
Results
Most of the single mutants had a significant response to phorbol 12-myristate 13-acetate (PMA)
Wild-type and 21 independent variants of ClC-1 were heterologously expressed in Xenopus oocytes to investigate the effect of PMA (a PKC activator) on ClC-1 channels. The wild-type ClC-1 currents show a significant change in the channels' gating properties after addition of PMA (2 µM) (Fig. 1) . The half-maximum activation voltage (V 1/2 ) was significantly right-shifted from -42.9 ± 4.4 to -13.7 ± 1.7 mV (n = 8, P < 0.05) before and after application of PMA, respectively. There are no significant differences in V 1/2 values between the mutants (S682A, S740A and T782A) and wild-type . The activation curves of each of these mutants (S682A, S720A, S740A and T782A) are sensitive to the treatment with PMA, which result in a significant right-shift of V 1/2 to more positive potentials respectively (on the right side of Fig.  1B to Fig. 1E ). The left sides of Fig. 1A to 1E show typical current traces through ClC-1 channel in response to voltage pulse. Here we show only some examples of current traces with single mutants. The summarized data of other single mutants with a significant response to PMA are shown in Fig. 5 .
The effects of PMA on T890A, T891A, S892A, and S892P The C-terminal tail of ClC-1 contains a region with four successive residues of Thr-Thr-Ser-Thr at position 890 to 893, which are the potential targets for PKC. Point mutation of these potential residues was created for the study. There were no significant differences in V 1/2 among T890A ( Fig. 2A), T891A (Fig. 2B), S892A (Fig.  2C), S892P (Fig. 2D ), T893A and wild-type (see also Fig.5 ). T890A, T891A, S892A and T893A can also give rise to a right shift of V 1/2 significantly after the addition of PMA (Fig.5) . Interesting, S892P did not change in the voltage dependent activation curve and V 1/2 value after addition of PMA (after PMA: -39±4.5 mV, before PMA: -35.7±5.7 mV; n = 6) (Fig.5) . Furthermore, the effect of PMA on the conductance (at -40 mV) of S892P (64.2 ± 9.6 µS vs after PMA 57.6 ± 8.8 µS, n = 6) showed no change as compared to wild-type (64.1 ± 3.8 µS vs after PMA 38.4 ± 2.3 µS, n = 8, P < 0.05). In a word, the replacement of serine by proline at residue 892 of ClC-1 causes a loss of the response to the PKC activator PMA.
The properties of S892D
The S892D is designed for the mimicking of phosphorylation at the position 892 and may lead to a constitutive active state of a ClC-1 without the addition of PKC activator. The V 1/2 value of S892D alone is significantly shifted toward more positive potential as compared with the wild-type ( Fig. 3; S892D , -10.2 ± 4.9 mV vs. wild-type, -42.9 ± 4.4 mV, P < 0.05; n = 4 -8), and can mimic the effect of wild-type treated with PMA (wild-type plus PMA, -13.7 ± 1.7 mV, n = 8). There is no significant change in V 1/2 of S892D between before and after PMA treatment (Fig. 3D and Fig.5 ; before PMA: -10.2 ± 4.9 mV, after PMA: -9.6 ± 3.5 mV, n = 4). The representative traces of wild-type and S892D in response to PMA stimulation are illustrated in Fig. 3A and 3B, respectively. Double mutants, T891A/S892A, T891A/T893A and S892A/T893A are less sensitive to PMA Considering the different effects between the S892P and S892A induced by PMA, the proline may result in a more drastic conformational change than the alanine in a putative PKC-phosphorylation region. This raises the possibility that other sites responsible for the gating effects by PMA might exist in the region around the residue 892. Fig. 3 . The effects of PMA on S892D mutation. The constitutive phosphorylation of ser892 can be mimicked by mutation of serine to aspartic acid. The wild-type and S892D currents before and after PMA treatment are shown in (A) and (B), respectively. The PMA treatment did not change in the voltagedependent activation curve of S892D current (D). The superimposed activation curves of S892D, wild-type and wild-type plus PMA (C) are shown in Fig. (E) , the V 1/2 value of S892D alone was close to the wild-type treated with PMA (E). In order to cause a more drastic change in the putative PKC recognition motif, we designed double mutations of ClC-1. The V 1/2 values showed no significant differences between double mutants (T891A/S892A, T891A/T893A and S892A/T893A) and wild-type (Fig. 5) . However, unlike the wild-type, these three double mutants are resistant to the effect of PMA (Fig. 5) . The V 1/2 values of double mutants T891A/S892A, T891A/T893A and S892A/T893A between before and after PMA treatment are -43.9 ± 3.8 mV vs -36 ± 7.9 mV (n = 4), -34. S682A, S720A,  P727L, S740A, T782A, T782R, S798A, S886R, T890A,  T891A, S892A, T893A, S896R , S902A, S903A, T929A and S933A by PMA were significantly shifted to more positive potentials. However, S892P, S892D, T891A/ S892A, S892A/T893A and T891A/T893A are no significant changes in V 1/2 between before and after the treatment with PMA. The conductances (at -40 mV) of these double mutants are also not affected by PMA treatment (Data not shown).
Discussion
In a previous study, Rosenbohm et al. showed that the external application of PMA reduced the human ClC-1 current amplitude expressed in HEK 293 cells [9] . This effect was abolished by perfusion with a specific antagonist of PKC intracellularly and concludes that the human ClC-1 channel activity is regulated by PKC. However, the phosphorylation sites on ClC-1 for PKC have not been determined. The truncation after the CBS1 of ClC-1 C-terminus gave no current [20] , which was due to a failure to reach the plasma membrane [20, 21] . It is still not known whether the C-termini of ClC-1 had a role in the regulation of channel activity. The intracellular C-terminal sequences of mammalian ClC proteins are longer than those of the non-mammalian counterparts and are likely to be involved in channel regulation [22] . Human ClC-1 has several putative serine/threonine phosphorylation sites in the C-terminal region. For prediction of phosphorylation sites in ClC-1, NetPhos 2.0 [16] was utilized. NetPhosK 1.0 [17] was also used to find the potential of ClC-1 cytoplasmic domains for their specificity to be phosphorylated by PKC at Ser/Thr. In this study, we constructed a series of mutated ClC-1 genes at the predicted phosphorylation sites and expressed the corresponding proteins in Xenopus oocytes. Subsequently, functional analysis of these mutants was performed in order to detect those among them which are not affected by the application of PMA (a PKC activator). The screening for ClC mutations with functional analysis showed that most of the single mutants were a significant right shift in V 1/2 induced by PMA except the S892P and S892D. Since proline gives the backbone a special rigidity rather than alanine [23] , S892P causes a more drastic conformational change of C-terminal domain rather than S892A. This conformational change of S892P may result in loss of response to PMA. In this study we show that the voltage-dependent gating property of S892P (Fig.2D) is indeed unaffected by PMA (Fig. 2C) . This result implied that a sequence containing serine at 892 of ClC-1 could, at least in part, serve as one of the targets for phosphorylation by PKC. Although S892A remains the response to the PKC activator, it can be explained that a minor conformational change caused by S892A could not interfere completely with other possible recognition sites for PKC (e.g., Thr890, Thr891 or Thr893).
Substitution of aspartic acid is a generally accepted method to mimic constitutive phosphorylation due to the introduction of a negative-charged functional group [24, 25] .The S892D did result in a significant right shift of V 1/2 compared with wild-type and to mimic the effect of PMA on wild-type ClC-1 current (Fig. 3B) . However, the serine at position of 892 could not the only phosphorylation site for PKC due to the S892A still have a significant response to PMA. A search through the protein sequence analysis of ClC-1 showed a potential ClC-1 and Phosphorylation Sites sequence with multiple phosphorylation sites from Thr890 to Thr893. Therefore, double mutants within the region between Thr891 to Thr893 were generated in this study. Each of these double mutants would expect to make a more drastic change in the protein structure than that of either single mutation alone. All double mutants (T891A/ S892A, T891A/T893A and S892A/T893A) were much less sensitive to the effect of PMA (e.g., the V 1/2 values) than that in each of the single mutants (T891A, S892A and T893A) and the wild-type. However, we cannot rule out the possibility that some mammalian proteins traffic differently when heterologously expressed in Xenopus oocytes [26] . The chloride currents properties of each of these double mutants alone (without the drug added) are similar to the wild-type indicated that these mutants may not interfere with their cell membrane surface expression. PKC typically phosphorylates serine/threonine residues in basic sequences but displays significantly less specificity than protein kinase A [27] . Three amino acid residues in the ClC-1 C-terminus, Thr891, Ser892 and Thr893 (residues from 888 to 896 are RNTTSTRKS), all fitted with the pattern of consensus sequence R/K-XSer/Thr or Ser/Thr-X-R/K [27] for PKC. Multiple alignment of human ClC-1 amino acid sequence showed about 87% identity to other mammalian ClC-1 sequences (rat and mouse). A multiple alignment including a sequence of human ClC-1 Thr891-Ser892-Thr893 is illustrated below.
Human ClC-1 C-terminal residues Thr891 and ser892 are highly conservation, which are correspond to Thr897 and Ser898 of rodent respectively. In this study the results of functional experiments in double mutants, T891A/S892A, S892A/T893A and T891A/T893A, indeed demonstrated that these residues are essential for the effect of PKC activator. Our observations indicate that a region Thr891-Ser892-Thr893 is responsible for the effect of PKC activator on gating properties of ClC-1. These findings provide useful hints for PKC-target sites and add further information on the regulation of ClC-1.
